Medical/Pharmaceuticals

Telix at ANZSNM Annual Scientific Meeting 2025

MELBOURNE, Australia, May 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces a strong presence at the 55th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM ASM 2025), to be held in M...

2025-05-20 06:00 2645

The Hong Kong Breast Cancer Foundation's 20th Anniversary Gala Dinner Successfully Held

Fundraising to Support Breast Cancer  Patients and Promote Breast Health Education HONG KONG, May 19, 2025 /PRNewswire/ -- Around 600 guests attended the 20th Anniversary Gala Dinner hosted by The Hong Kong Breast Cancer Foundation (HKBCF), raising funds to support breast cancer patients and pr...

2025-05-19 23:47 2084

Shanton to Present Topline Data from Phase 2b Study with SAP-001 in Refractory Gout Patients at EULAR 2025 Congress

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., May 19, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that it will be pre...

2025-05-19 21:00 2373

Cell Impact delivers flow plates and test tools to a major player in Asia

KARLSKOGA, Sweden, May 19, 2025 /PRNewswire/ -- Cell Impact AB (publ) has signed an agreement to deliver test tools to a leading industrial player in Asia. The deal confirms Cell Impact's attractive offering and its unique forming technology. The agreement is a follow-up order from a customer wi...

2025-05-19 17:20 2236

AIM Vaccine's Next-Gen mRNA Shingles Vaccine Secures Clinical Approvals in Both PRC and U.S. ,mRNA Platform Advantages Shine Through

HONG KONG, May 19, 2025 /PRNewswire/ -- While global giants like Moderna and BioNTech apply mRNA technology to broader disease markets, PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660.HK), a leading domestic vaccine company, announced today that its self-developed mRNA shingles vaccine...

2025-05-19 08:30 4633

Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation

SAN FRANCISCO and SUZHOU, China, May 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2025-05-19 08:00 3655

CathWorks Announces Key Events for EuroPCR 2025

NEWPORT BEACH, Calif. and AMSTERDAM, May 16, 2025 /PRNewswire/ -- CathWorks, a global leader in digital health innovations, announced today the schedule of key events for the company during the upcoming EuroPCR 2025 conference taking place May 20 to 23 at the Palais des Congrès in Paris, France. ...

2025-05-16 22:05 2880

Gene Solutions and NEWCL Forge Strategic Partnership to Advance Genetic Testing in Taiwan

NEW TAIPEI CITY, May 16, 2025 /PRNewswire/ -- In a groundbreaking move, Gene Solutions , a leader in prenatal and oncology genetic testing, andNEWCL Biomedical Laboratory , Taiwan's pioneering clinical laboratory with LDTs certification, have joine...

2025-05-16 19:06 3229

Nuance Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-CHINA Trial for COPD

Statistically significant improvements in lung function Consistent trends of quality of life and exacerbation rate reduction as ENHANCE-1/2 Well tolerated safety profile NDA submission planned for 2H 2025 SHANGHAI, May 16, 2025 /PRNewswire/ -- Nuance Pharma ("Nuance") today announces its top-lin...

2025-05-16 15:49 3642

MINISH Veneers Expands Global Footprint with Successful Dental Seminar in Los Angeles

SEOUL, South Korea, May 16, 2025 /PRNewswire/ -- Korean healthtech company MINISH Technology hosted a successful dental seminar and business briefing in Los Angeles on May 10th, marking its second international event and a key step in its North American expansion - following its successful launch...

2025-05-16 14:52 3546

Nordic Bioscience launches novel Endotrophin assay

HERLEV, Denmark, May 16, 2025 /PRNewswire/ -- Nordic Bioscience introduces nordicEndotrophin™, a fully automated high-precision assay that selectively quantifies the intact 77-amino-acid Endotrophin signaling hormone—qualified in the CAP/CLIA certified Nordic Bioscience laboratory. When integrate...

2025-05-16 14:30 2287

Amorepacific and Johns Hopkins School of Medicine's Joint Research Program 'NBRI' Participants Present Latest Findings

Skin anti-aging and immunity effects of Amorepacific's two proprietary ingredients,  'RE.D Flavonoid' and 'Senomune' revealed at the 2025 SID Annual Meeting SEOUL, South Korea, May 16, 2025 /PRNewswire/ -- Amorepacific has demonstrated the efficacy of its two proprietary ingredients in improving ...

2025-05-16 13:00 3103

PHKL Showcases Robotic Precision in Orthopaedic Care

KUALA LUMPUR, Malaysia, May 16, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) recently hosted its first-ever Ortho Experience Day, offering a rare, hands-on look at the hospital's cutting-edge MAKO Robotic Surgery System—a transformative tool in joint replacement procedures.

2025-05-16 12:19 2160

ArkBio Announces Positive Phase II Results of AK3280 for Treatment of Idiopathic Pulmonary Fibrosis (IPF)

SHANGHAI, May 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treatment of idiopathic pulmonary fibrosis (IPF). The study, led by Professor Huaping Dai of the Departmen...

2025-05-16 09:00 3067

Second Head-to-head Phase 3 Study of Mazdutide versus Semaglutide Completes First Participant Dosing in Adults in China with Overweight or Obesity Accompanied Fatty Liver Disease (GLORY-3)

SAN FRANCISCO and SUZHOU, China, May 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...

2025-05-16 08:00 7178

Fotona® Appoints Jeff Duchemin as Group President and CEO

Duchemin brings global MedTech leadership experience to accelerate Fotona's next phase of growth DALLAS , May 15, 2025 /PRNewswire/ -- FotonaⓇ, a global leader in high-performing laser systems and energy-based devices for aesthetic, dental and gynecological applications, today announces the app...

2025-05-15 23:00 2925

CIT Srl Charts a Visionary Path in Supply Chain Digitalization with TraceLink's Multienterprise Information Network Tower (MINT)

BOSTON, May 15, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, today announced thatCIT Srl, a rapidly growing contract packaging organization (CPO) based in the European Union, has selected TraceLink's Multienterprise In...

2025-05-15 22:00 2240

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays

First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to advance neurodegenerative disease research FREMONT, Calif., May 15, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, tod...

2025-05-15 21:13 2910

STEERLife Redefines Potent Drug Development with Clean, Green, Continuous Processing

As a next-gen CRDMO, driving global pharma with continuous, solvent-free tech for potent drug development BENGALURU, India, May 15, 2025 /PRNewswire/ -- STEERLife, the life sciences division of STEER World, is advancing the development and manufacturing of potent and complex drug products. This...

2025-05-15 20:07 1792

Intalight™ Receives CE Mark for Its Progressive DREAM OCT™ Swept Source Imaging

SAN JOSE, Calif. and SHANGHAI, May 15, 2025 /PRNewswire/ -- Intalight™, a company that develops advanced ophthalmic technologies and a leader in Optical Coherence Tomography (OCT) today announced it has received CE mark for its  DREAM OCT™ platform. The CE mark serves as approval by the European ...

2025-05-15 20:00 2600
1 ... 52535455565758 ... 395

Week's Top Stories